Non Culprit Lesion Study
NCT02982057
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
STEMI
Interventions
DEVICE:
the ABSORB:bioresorbable vascular scaffold
DRUG:
O.M.T
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain